IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Landos Biopharma Inc

CUSIP: 515069102 | 84 institutional holders

Quarters

Q1 2024Q4 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Cornerstone Planning Group LLC12
0.0% of portfolio›$267
StyleTurnoverLocationFiled
Cornerstone Planning Group LLC
12$2670.0%ETFMediumFairfield, NJ2024-05-07